等待开盘 08-13 09:30:00 美东时间
-1.960
-1.63%
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Goldman Sachs analyst Aron Adamski downgraded Interparfums Inc (NASDAQ:IPAR) from Buy to Neutral ...
08-10 20:10
Goldman Sachs analyst Aron Adamski downgrades Interparfums (NASDAQ:IPAR) from Buy to Neutral and raises the price target from $110 to $129.
08-10 17:47
Inter Parfums (IPAR) declares $0.80/share quarterly dividend, in line with previous. Forward yield 2.49% Payable Sept. 30; for shareholders of record Sept. 15; ex-div Sept. 15. See IPAR Dividend Score...
08-05 16:54
华盛资讯8月5日讯,依特香水公布2026财年Q2业绩,公司Q2营收3.41亿美元,同比增长2.1%,归母净利润0.30亿美元,同比下滑4.7%。
08-05 07:17
华盛资讯8月5日讯,依特香水公布2026财年Q2业绩,公司Q2营收3.41亿美元,同比增长2.1%,归母净利润0.30亿美元,同比下滑4.7%。
08-05 04:52
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37
今日重点评级关注:伯恩斯坦:维持ServiceNow"跑赢大市"评级,目标价从236美元升至248美元;HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从46美元升至52美元
07-24 11:37
Canaccord Genuity analyst Susan Anderson maintains Interparfums (NASDAQ:IPAR) with a Buy and raises the price target from $123 to $141.
07-24 00:56
Inter Parfums press release (IPAR): Q2 Total revenue of $341M (+2.1% Y/Y). H1 net sales: $686M (+2% Y/Y). European sales: Q2 $231M (-4% Y/Y); H1 $483M (-1% Y/Y) U.S. sales: Q2 $113M (+18% Y/Y); H1 $2...
07-23 18:10